Novolog Mix 70/30 Injection, Suspension
Product Images NDC 50090-2272

Product Visual Gallery

This gallery contains 49 technical images submitted to the FDA as part of the official labeling for Novolog Mix 70/30 (NDC 50090-2272). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Graph Showing Mean Serum Insulin For Novolog Mix 70/30 (Export 04)

A line graph showing the mean serum insulin levels (mU/L) over a 24-hour period for NOVOLOG MIX 70/30. The x-axis represents time in hours, and the y-axis represents mean serum insulin concentration. The graph includes error bars representing the standard error of the mean (SEM).*

FDA Label Image

Graph Showing Glucose Infusion Rate For Novolog Mix 0/30 (Export 05)

A line graph depicting the glucose infusion rate (mg/kg/min) over a 24-hour period for NOVOLOG MIX 70/30. The graph shows a rapid increase to a peak between 1 and 2 hours followed by a gradual decline, approaching near zero infusion rate by 24 hours.*

FDA Label Image

Molecular Chain Of Insulin Aspart. (Image 01)

Chemical structure diagram showing the amino acid sequence and disulfide bonds of the A-chain and B-chain of an insulin molecule. The diagram highlights the specific amino acids and sulfur-sulfur linkages connecting the chains.*

FDA Label Image

Flexpen Components (Image 04)

An exploded view illustration of the NovoLog Mix 70/30 FlexPen insulin injection device showing labeled components: pen cap, rubber stopper, 12 glass units, ball cartridge, cartridge scale, pointer, dose selector, and push-button.*

FDA Label Image

Needle Components. (Image 05)

An instructional illustration showing components of three injection pen needles: NovoFine, NovoFine Plus, and NovoTwist. Each set depicts a big outer needle cap, inner needle cap, needle, and protective tab arranged from left to right.*

FDA Label Image

Figure D: Screw Needle On. (Image 06)

Instructional illustration showing steps to connect a NovoFine or NovoFine Plus needle to a NovoTwist device, likely part of an insulin injection system. The diagram demonstrates aligning and attaching the needle to the pen device.*

FDA Label Image

Image Of Possible Injection Sites. (Image 09)

An illustration showing the front and back views of a human torso, highlighting the abdominal and upper buttock areas as common injection sites. This figure is typically used to indicate appropriate injection sites for subcutaneous administration.*

FDA Label Image

Important (Image 10)

FDA Label Image

Important (Image 11)

FDA Label Image

Important (Image 12)

FDA Label Image

Important (Image 13)

FDA Label Image

Important (Image 14)

FDA Label Image

Important (Image 15)

FDA Label Image

Important (Image 16)

FDA Label Image

Important (Image 17)

FDA Label Image

Important (Image 18)

FDA Label Image

Important (Image 19)

FDA Label Image

Important (Image 20)

FDA Label Image

Important (Image 21)

FDA Label Image

Important (Image 22)

FDA Label Image

Important (Image 23)

FDA Label Image

Important (Image 24)

FDA Label Image

Figure E: Pull Off Outer Needle Cap. (Image 25)

An instructional illustration showing steps for using an injection device. The left panel labeled 'NovoFine NovoFine Plus' depicts a hand adjusting a needle cap. The right panel labeled 'NovoTwist' shows a hand twisting a needle cap. Blue arrows indicate the direction of cap removal in each method.*

FDA Label Image

Figure F: Pull Off Inner Needle Cap. (Image 26)

An instructional illustration showing two steps for using NovoFine and NovoTwist devices. The left panel depicts a hand gripping the NovoFine needle, while the right panel shows a hand attaching or twisting the NovoTwist component onto the pen or syringe.*

FDA Label Image

Vial Figure (Image 35)

Illustration of a vial showing a tamper-resistant cap and a rubber stopper under the cap. The image highlights the vial's sealing components but provides no product-specific labeling.*

FDA Label Image

Hand & Vial Figure (Image 36)

An illustration showing a hand holding a small vial upright between thumb and fingers, demonstrating proper handling of the vial for NOVOLOG MIX 70/30 100 IU/mL.*

FDA Label Image

Figure A & Figure B (Image 37)

An instructional illustration showing two steps for handling an injection bottle with a cap; one hand holding the bottle while the other removes the cap, depicted in two panels labeled Figure A and Figure B.*

FDA Label Image

Figure C (Image 38)

An instructional illustration labeled Figure C showing two hands positioned palm to palm, with an arrow indicating a back-and-forth motion. This suggests a step involving hand movement or rubbing as part of a procedure.*

FDA Label Image

Figure D (Image 39)

An instructional diagram showing a hand holding a syringe above a vial, with an arrow indicating downward movement to draw liquid from the vial into the syringe. A close-up inset highlights the syringe barrel filled with liquid.*

FDA Label Image

Figure E (Image 40)

An instructional illustration labeled Figure E showing hands drawing liquid into a syringe from a vial or pen device. The image demonstrates proper technique for preparing an injection, relevant to the NOVOLOG MIX 70/30 insulin product.*

FDA Label Image

Figure F (Image 41)

An instructional illustration showing a hand holding a syringe. An arrow points to the top of the syringe, indicating a step in the injection or preparation process. The image is labeled as Figure F.*

FDA Label Image

Figure G (Image 42)

Illustration showing the preparation of an injection with a vial and syringe held by hands. The vial is inverted with an arrow indicating the direction of fluid withdrawal into the syringe, demonstrating a step in the medication preparation process.*

FDA Label Image

Figure H (Image 43)

Instructional diagram showing the proper method to draw liquid from a vial into a syringe, depicting hands holding the syringe and vial in a vertical position.*

FDA Label Image

Figure I (Image 44)

An instructional illustration showing a hand drawing medication from a vial into a syringe. The parts are labeled as Figure 1, depicting the process of lifting the vial and withdrawing liquid with the syringe.*

FDA Label Image

Figure J (Image 45)

Instructional illustration labeled as Figure J showing a hand holding a syringe and another hand holding a vial, with an arrow indicating the action of drawing medication from the vial into the syringe. This image is associated with NOVOLOG MIX 70/30 insulin 100 [iU]/mL by A-S Medication Solutions.*

FDA Label Image

Figure L (Image 47)

Illustration showing the hands holding a syringe with an arrow indicating downward movement, possibly demonstrating how to draw medication or remove air from the syringe. The black arrow points downward toward the syringe barrel.*

FDA Label Image

Figure M (Image 48)

An instructional illustration showing a hand holding a syringe and pulling back the plunger to draw medication, with another hand holding an arm ready for injection. The image serves as a step in preparing an injection, labeled as Figure M.*

FDA Label Image

Pull Off The Pen Cap. (Image 50)

An instructional illustration showing the use of a pen-style injector device. The image depicts a hand gripping the device and pressing it forward, with arrows indicating the motion direction.*

FDA Label Image

Roll The Pen Between Your Palms. (Image 51)

An instructional illustration showing the proper method to roll a vial or pen of medication between the palms of the hands. The image depicts two hands with arrows indicating a horizontal rolling motion, suggesting how to gently mix the content before use, relevant for the NOVOLOG MIX 70/30 insulin product.*

FDA Label Image

Move The Pen Up And Down. (Image 52)

An instructional illustration showing a two-step process of preparing a medication cartridge or syringe. Step 1 depicts holding the cartridge upright, while step 2 shows turning it horizontally. The image visually guides proper handling technique without text instructions.*

FDA Label Image

Turn The Dose Selector To 2 Units. (Image 56)

An instructional diagram showing the dosing window of a NOVOLOG MIX 70/30 insulin pen. The image depicts a hand holding the pen, with the dose selector set to 2 units, illustrating how to read the unit dose selected on the device.*

FDA Label Image

Tap The Needle. (Image 57)

An instructional illustration showing a hand holding a syringe near the needle tip. Sound waves indicate that the user should tap or flick the syringe to remove air bubbles before injection.*

FDA Label Image

Press The Push-button. (Image 58)

An instructional illustration showing a hand holding a pen injector device with an arrow pointing upward, indicating to pull or remove the cap. The bottom inset inset shows a close-up of the pen cap being removed from the injector, consistent with initial preparation steps for using an injection pen, likely for NOVOLOG MIX 70/30 insulin.*

FDA Label Image

Select Your Dose. (Image 59)

An illustrated instructional diagram showing a close-up of a hand adjusting a dosage pen for insulin injection. The image highlights selecting 5 units and then 24 units on the dose indicator of the pen, demonstrating dose setting increments in two steps.*

FDA Label Image

Press The Push Button To Inject. (Image 60)

An instructional illustration showing a hand twisting or turning the blue cap of a vial labeled NOVOLOG MIX 70/30 100 [iU]/mL to open it, indicating the method to remove the vial cap before use.*

FDA Label Image

Keep The Needle In The Skin For At Least 6 Seconds. (Image 61)

An instructional diagram illustrating the use of a pen-type injector. The image shows the needle tip positioned near the skin surface, indicating the injection process typically associated with insulin delivery.*

FDA Label Image

Replace The Pen Cap. (Image 62)

An instructional illustration showing a close-up of a pen-style injection device with a blue arrow indicating a twist or turn motion, likely demonstrating how to prepare or adjust the device before use.*

FDA Label Image

Label Image (Lbl500902272)

Label of NOVOLOG MIX 70/30 100 units/mL prefilled syringes by A-S Medication Solutions. The label indicates 5 syringes of 3 mL each, storing instructions to refrigerate at 36 to 46 degrees Fahrenheit and protect from light, and notes each unit contains 100 units of insulin aspart.*

FDA Label Image

Label Image (Lbl500902273)

Label for NOVOLOG MIX 70/30 injectable suspension, 100 units/mL, supplied in a 10 mL vial. The label includes storage instructions to keep the vial at 36 to 46 degrees Fahrenheit, protected from light. Distributed by A-S Medication Solutions, Libertyville, IL. Manufacturer mentioned as Novo Nordisk A/S, Denmark.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.